This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lin, W.-c. Articles by Culp, L. A. Search for Related Content PubMed PubMed Citation Articles by Lin, W.-c. Articles by Culp, L. A.

Bacterial lacZ Gene as a Highly Sensitive Marker to Detect Micrometastasis Formation during Tumor Progression¹

Department of Molecular Biology and Microbiology [W-C. L., L. A. C.], and Department of Pathology [T. P. P., T. G. P. II], Case Western Reserve University, School of Medicine, Cleveland, Ohio 44106

During tumor progression, micrometastases at their earliest stages have been difficult to analyze qualitatively or quantitatively because of a lack of suitably sensitive markers to discriminate small numbers of tumor cells from normal tissue cell populations. To overcome this problem, the Escherichia coli ß-galactosidase (lacZ) gene was introduced into human EJ Ha-ras oncogene-transfected BALB/c 3T3 cells with subsequent injection of transfected cells into athymic nude mice. Using a chromogenic substrate (5-bromo-4-chloro-3-indoyl-ß-D-galactopyranoside), the lacZ-bearing tumor cells at primary tumor sites as well as at secondary organs stain intensely blue and can be easily distinguished from the host tissue cells hours, days, or weeks postinjection. Staining of lacZ-bearing tumor cells is specific and extremely sensitive in detecting micrometastatic foci in lungs and other organs, including brain and kidney for the first time. Stable integration of the lacZ and ras genes into cultured cells and subsequent tumor cells was verified by Southern blot analyses. The lacZ gene appears to be a stable marker during tumor progression in vivo based both on phenotypic (5-bromo-4-chloro-3-indoyl-ß-D-galactopyranoside staining) and on genotypic (Southern blot analysis) evidence. Furthermore, 5-bromo-4-chloro-3-indoyl-ß-D-galactopyranoside staining of tumor cells can also be used together with alkaline phosphatase staining relatively specific for endothelial cells to relate the topographies of metastatic cells and host blood vessels in embedded sections. By using the lacZ gene as a sensitive quantitative marker, analyses of micrometastasis development in the lung indicate that the ras oncogene contributes to the metastatic phenotype in this EJ Ha-ras model system, although further genetic and/or phenotypic alterations appear to be necessary for long-term growth and development into overt metastases. These findings demonstrate the effectiveness and sensitivity of the bacterial lacZ gene as a phenotypic marker in tumor progression studies, providing both a qualitative and a quantitative tool in virtually any tumor system for examining micrometastasis formation in target organs and the relationship of tumor cells to host organ microenvironments.

¹ This work is supported by NIH Research Grants R01-CA27755 (L. A. C.) and R01-CA48032 (T. P. P.). Case Western Reserve University is a comprehensive cancer center supported by USPHS Grant P30CA43703, awarded by the National Cancer Institute, Department of Health and Human Services.

² To whom requests for reprints should be addressed.

Received 11/15/89.

This article has been cited by other articles:

				P. T. Winnard Jr., A. P. Pathak, S. Dhara, S. Y. Cho, V. Raman, and M. G. Pomper Molecular Imaging of Metastatic Potential J. Nucl. Med., June 1, 2008; 49(Suppl_2): 96S - 112S. [Abstract] [Full Text] [PDF]

				K. Tsuji, K. Yamauchi, M. Yang, P. Jiang, M. Bouvet, H. Endo, Y. Kanai, K. Yamashita, A. R. Moossa, and R. M. Hoffman Dual-Color Imaging of Nuclear-Cytoplasmic Dynamics, Viability, and Proliferation of Cancer Cells in the Portal Vein Area Cancer Res., January 1, 2006; 66(1): 303 - 306. [Abstract] [Full Text] [PDF]

				M. Suggitt and M. C. Bibby 50 Years of Preclinical Anticancer Drug Screening: Empirical to Target-Driven Approaches Clin. Cancer Res., February 1, 2005; 11(3): 971 - 981. [Abstract] [Full Text] [PDF]

				N. El Hilali, N. Rubio, and J. Blanco Different Effect of Paclitaxel on Primary Tumor Mass, Tumor Cell Contents, and Metastases for Four Experimental Human Prostate Tumors Expressing Luciferase Clin. Cancer Res., February 1, 2005; 11(3): 1253 - 1258. [Abstract] [Full Text] [PDF]

				S. Paris and R. Sesboue Metastasis models: the green fluorescent revolution? Carcinogenesis, December 1, 2004; 25(12): 2285 - 2292. [Abstract] [Full Text] [PDF]

				N. Yamamoto, P. Jiang, M. Yang, M. Xu, K. Yamauchi, H. Tsuchiya, K. Tomita, G. M. Wahl, A. R. Moossa, and R. M. Hoffman Cellular Dynamics Visualized in Live Cells in Vitro and in Vivo by Differential Dual-Color Nuclear-Cytoplasmic Fluorescent-Protein Expression Cancer Res., June 15, 2004; 64(12): 4251 - 4256. [Abstract] [Full Text] [PDF]

				B. S. Nielsen, L. R. Lund, I. J. Christensen, M. Johnsen, P. A. Usher, L. Wulf-Andersen, T. L. Frandsen, K. Dano, and H. J. G. Gundersen A Precise and Efficient Stereological Method for Determining Murine Lung Metastasis Volumes Am. J. Pathol., June 1, 2001; 158(6): 1997 - 2003. [Abstract] [Full Text] [PDF]

				J. L. Holleran, C. J. Miller, and L. A. Culp Tracking Micrometastasis to Multiple Organs with lacZ-tagged CWR22R Prostate Carcinoma Cells J. Histochem. Cytochem., May 1, 2000; 48(5): 643 - 652. [Abstract] [Full Text]

				M. Yang, P. Jiang, Z. An, E. Baranov, L. Li, S. Hasegawa, M. Al-Tuwaijri, T. Chishima, H. Shimada, A. R. Moossa, et al. Genetically Fluorescent Melanoma Bone and Organ Metastasis Models Clin. Cancer Res., November 1, 1999; 5(11): 3549 - 3559. [Abstract] [Full Text] [PDF]

				L. A. Culp, W.-c. Lin, N. R. Kleinman, K. L. O'Connor, and R. Lechner Earliest Steps in Primary Tumor Formation and Micrometastasis Resolved with Histochemical Markers of Gene-tagged Tumor Cells J. Histochem. Cytochem., May 1, 1998; 46(5): 557 - 568. [Abstract] [Full Text]